Recruiting OBSERVATIONAL NCT06627335

An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis Exposed to Ruxolitinib Cream Versus Topical Corticosteroids During Pregnancy: A US Claims Database Analysis

Pregnancy Outcomes Study of Women With Atopic Dermatitis Exposed to Ruxolitinib Cream Versus Topical Corticosteroids During Pregnancy: A US Claims Database Analysis

Sponsor: Incyte Corporation

Conditions Atopic Dermatitis Pregnancy Related

Interventions Ruxolitinib Cream TCS

Updated 4 times since 2024 Last updated: Dec 4, 2025 Started: Mar 27, 2023 Primary completion: Aug 15, 2027 Completion: Aug 15, 2028

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT06627335, this observational or N/A phase trial focuses on Atopic Dermatitis and Pregnancy Related and remains actively recruiting participants. Sponsored by Incyte Corporation, it has been updated 4 times since 2023, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

4 versions recorded

Jan 2026 — Present [monthly]

Recruiting
Aug 2025 — Jan 2026 [monthly]

Recruiting
Jan 2025 — Aug 2025 [monthly]

Recruiting
Nov 2024 — Jan 2025 [monthly]

Recruiting

First recorded

Mar 2023

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Incyte Corporation

Data source: Incyte Corporation

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Morrisville, United States